Cargando…

Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”

Detalles Bibliográficos
Autores principales:	Macià, A., Herreros, J., Martí, R. M., Cantí, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005520/ https://www.ncbi.nlm.nih.gov/pubmed/27610370 http://dx.doi.org/10.1155/2016/3017536

Ejemplares similares

Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma
por: Macià, A., et al.
Publicado: (2015)

T-Type Calcium Channels: A Potential Novel Target in Melanoma
por: Barceló, Carla, et al.
Publicado: (2020)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
por: Babiker, HM, et al.
Publicado: (2019)

Dissolution Rates of Calcium Boluses and Their Effects on Serum Calcium in Dairy Cattle [Corrigendum]
Publicado: (2021)

Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo”
por: Ho, Mao-Lin, et al.
Publicado: (2015)

Ex vivo distribution of gold nanoparticles in choroidal melanoma [Corrigendum]
Publicado: (2018)

[Corrigendum] Melanogenesis in uveal melanoma cells: Effect of argan oil
por: Caporarello, Nunzia, et al.
Publicado: (2023)

Corrigendum to: Calcium Signaling in the Photodamaged Skin: In Vivo Experiments and Mathematical Modeling
Publicado: (2022)

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Publicado: (2017)

CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma
Publicado: (2019)

Corrigendum: Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells
por: Park, Doyeon, et al.
Publicado: (2022)

Corrigendum to “Plasma Albumin Induces Cytosolic Calcium Oscilations and DNA Synthesis in Human Cultured Astrocytes”
por: Vega-Zelaya, Lorena, et al.
Publicado: (2016)

Corrigendum: Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
Publicado: (2022)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Application of Radiosensitizers in Cancer Radiotherapy [Corrigendum]
Publicado: (2021)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency [Corrigendum]
Publicado: (2016)

Corrigendum to “AOSpine Consensus Paper on Nomenclature for Working-Channel Endoscopic Spinal Procedures”
Publicado: (2021)

Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum]
Publicado: (2021)

Construction of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy [Corrigendum]
Publicado: (2022)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Corrigendum: Drosophila Plc21C is involved in calcium wave propagation during egg activation
Publicado: (2020)

Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus [Corrigendum]
Publicado: (2018)

PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer [Corrigendum]
Publicado: (2023)

Corrigendum to “New and Emerging Therapies for Osteoporosis”
por: Lewiecki, E. Michael, et al.
Publicado: (2017)

Corrigendum to “Cell therapies in ovarian cancer”
Publicado: (2021)

Antibacterial Properties of PEKK for Orthopedic Applications [Corrigendum]
Publicado: (2021)

Corrigendum: Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2022)

Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”
por: Zhang, Lingyun, et al.
Publicado: (2021)

Corrigendum to “Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest”
por: Adams, Anngela C., et al.
Publicado: (2022)

Corrigendum: A histamine-gated channel is an efficient negative selection marker for C. elegans transgenesis
Publicado: (2021)

Improving attitudes toward electroconvulsive therapy – CORRIGENDUM
por: Cheung, Oakley, et al.
Publicado: (2022)

Corrigendum to “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy”
por: Bhat, Abhishek, et al.
Publicado: (2019)

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum]
Publicado: (2019)

Corrigendum to: microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus
Publicado: (2023)

Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies [Corrigendum]
Publicado: (2015)

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study [Corrigendum]
Publicado: (2018)

CORRIGENDUM
por: Sethi, Sujata, et al.
Publicado: (2001)

Corrigendum to: Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies
por: Taramasso, Maurizio, et al.
Publicado: (2020)

Corrigendum to: Two Functional Epithelial Sodium Channel Isoforms Are Present in Rodents despite Pronounced Evolutionary Pseudogenization and Exon Fusion
por: Gettings, Sean M, et al.
Publicado: (2021)

Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect [Corrigendum]
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d155eb95ae0gi4sohb0juc0teq